Clinical Trials in Baltimore, MD

Browse 241 Clinical Trials Baltimore Across 1053 Cities
84 Phase 3 Trial · 8676 Clinical Trials Baltimore Clinics

Display Results

All

Most EffectiveMost SafeSenior FriendlyPediatricNo Placebo

Clinical Trials Clinical Trials in Baltimore, MD

Reviewed by Michael Gill, B. Sc.

Image of Johns Hopkins University in Baltimore, United States.

Phase-Based Progress Estimates

SWAN Motion Sick Daytonfor Airsickness

The investigators have developed a self-administered rehabilitation tool that incrementally guides the user to increase head motion to mitigate motion sickness and enhance postural recovery following centrifugation or unilateral vestibular nerve deafferentation surgery.

Johns Hopkins University (+1 Sites)Matthew Stewart, MD PhD

Image of Care Access Mobile Site in New London, United States.

Phase-Based Progress Estimates

VLA15for Lyme Disease

Senior-friendly

This trial is being conducted to test the safety and effectiveness of a Lyme disease vaccine.

Senior-friendly

Care Access Mobile Site (+57 Sites)Pfizer CT.gov Call CenterValneva Austria GmbH

Image of Kennedy Krieger Institute in Baltimore, United States.

Phase-Based Progress Estimates

Home Exercisefor Neurodegenerative Diseases

The primary goal of this study is to address the need for targeted therapeutic interventions for impairments that impact walking in related neurodegenerative diseases.

Kennedy Krieger InstituteJennifer Keller, PT

Image of University of Maryland School of Medicine in Baltimore, United States.

Phase-Based Progress Estimates

Remote Monitoringfor Ileocolitis

This trial will help assess whether or not a remote monitoring digital health system can improve adherence, clinical outcomes, and decrease healthcare utilization compared to standard care in participants with inflammatory bowel disease.

University of Maryland School of Medicine

Image of Retina-Vitreous Associates Medical Group in Beverly Hills, United States.

Phase-Based Progress Estimates

UBX1325for Age related macular degeneration

This trial will test if it is safe to give patients with wet AMD another injection of UBX1325.

Retina-Vitreous Associates Medical Group (+25 Sites)Unity Biotechnology, Inc.

Image of Prometheus Biosciences Selected Site in Los Angeles, United States.

Phase-Based Progress Estimates

PRA023 IVfor Diffuse Scleroderma

This trial is testing a new drug to see if it's safe and effective for people with a lung disease called SSc-ILD.

Prometheus Biosciences Selected Site (+9 Sites)Prometheus BiosciencesPrometheus Biosciences, Inc.

Image of City of Hope in Duarte, United States.

Phase-Based Progress Estimates

Daratumumabfor Amyloidosis

This trial is testing a new cancer treatment to see if it is safe for people with heart problems. The new treatment is a combination of drugs, and the trial will also look at how well it works in people of different racial and ethnic backgrounds.

City of Hope (+17 Sites)Janssen Research & Development, LLC Clinical TrialJanssen Research & Development, LLC

Image of University of Colorado, Anschutz Inpatient Pavilion 1 and 2 in Aurora, United States.

Phase-Based Progress Estimates

Real-time CGMfor Diabetes Mellitus, Type 2

This trial will study whether intensive management of glycemia in people with diabetes, using continuous glucose monitoring technology, is safe and feasible.

University of Colorado, Anschutz Inpatient Pavilion 1 and 2 (+5 Sites)Judy Sibayan, MPH, CCRPDexCom, Inc.

Image of MDACC in Houston, United States.

Phase-Based Progress Estimates

DSP-5336for Leukemia, Myeloid, Acute

This trial is testing a new drug for people with a certain type of blood cancer who have not responded to other treatments.

MDACC (+5 Sites)Sumitomo Dainippon Pharma Oncology, Inc

Image of University of Washinton in Seattle, United States.

Phase-Based Progress Estimates

Facilitated Group Supportfor Endometrial Neoplasms

This trial is looking at whether social support can help Black patients with endometrial cancer finish their treatment.

University of Washinton (+8 Sites)Kemi M Doll, MD, MS

Image of University of Florida in Jacksonville, United States.

Phase-Based Progress Estimates

TAR-200for Urinary Bladder Cancer

This trial will test the effectiveness of TAR-200, a new cancer drug, either alone or in combination with another immunotherapy drug, cetrelimab.

University of Florida (+29 Sites)Janssen Research & Development, LLC Clinical TrialJanssen Research & Development, LLC

Image of Investigative Site in San Francisco, United States.

Phase-Based Progress Estimates

Cohort 2c (VIR-2218 + VIR-3434)for Hepatitis B, Chronic

This trial is testing new drugs to treat hepatitis B. The drugs will be given to people who have the virus and researchers will see how well they work, how safe they are, and how well they are tolerated.

Investigative Site (+6 Sites)Vir Biotechnology, Inc.

Image of Care Access Research LLC in Berkeley, United States.

Phase-Based Progress Estimates

CDPATH™for Crohn Disease

This trial is testing a tool to help predict Crohn's disease complications and to aid discussions with doctors about the disease.

Care Access Research LLC (+73 Sites)Study DirectorTakeda

Image of Cardiology PC in Birmingham, United States.

Phase-Based Progress Estimates

Axon Treatment Armfor Heart Failure

This trial is testing a new treatment for heart failure that involves numbing a nerve to see if it improves symptoms.

Cardiology PC (+17 Sites)Axon Therapies, Inc.

Image of Johns Hopkins Bayview Medical Center in Baltimore, United States.

Phase-Based Progress Estimates

Omalizumabfor Nasal Polyps

FDA Approved Drug

This trial is testing a new drug to see if it can help with chronic sinusitis and nasal polyps.

FDA Approved Drug

Johns Hopkins Bayview Medical Center (+1 Sites)Jean Kim, MD PhDGenentech, Inc.

Image of Regeneron Study Site in Birmingham, United States.

Phase-Based Progress Estimates

Dupilumabfor Allergic Bronchopulmonary Aspergillosis

FDA Approved Drug

This trial will study the effects of the medication dupilumab on people with Allergic Bronchopulmonary Aspergillosis, specifically looking at the rate of exacerbations, lung function, health-related quality of life, and other measures.

FDA Approved Drug

Regeneron Study Site (+23 Sites)Clinical Trial ManagementSanofi

Image of University of Alabama at Birmingham Cancer Center in Birmingham, United States.

Phase-Based Progress Estimates

Radiation Therapyfor Breast

FDA Approved Drug

This trial is studying how well paclitaxel, trastuzumab, and pertuzumab work in eliminating chemotherapy after surgery in patients with HER2-positive stage II-IIIa breast cancer who have no cancer remaining at surgery.

FDA Approved Drug

University of Alabama at Birmingham Cancer Center (+99 Sites)Nadine M Tung

Image of CHI St. Vincent, Arkansas in Little Rock, United States.

Phase-Based Progress Estimates

Antiplatelet Therapyfor Bleeding

This trial is looking at whether adding oral anticoagulation to background antiplatelet therapy is effective and safe in preventing thromboembolic events in patients who develop new-onset atrial fibrillation after isolated coronary artery bypass graft surgery.

CHI St. Vincent, Arkansas (+56 Sites)Annetine C Gelijns, PhD

Image of Novo Nordisk Investigational Site in Hamilton, Canada.

Phase-Based Progress Estimates

Semaglutidefor Overweight

Waitlist Available

FDA Approved Drug

This trial is testing whether the drug semaglutide can reduce the risk of cardiovascular events (like heart attacks or strokes) in people who are overweight or obese and have already had one such event. People taking part will be randomly assigned to either take semaglutide or a placebo (dummy) drug, and neither they nor the researchers will know who is taking which. The trial will last for 2.5 to 5 years, with participants making up to 25 visits to the study doctor.

Waitlist Available

FDA Approved Drug

Novo Nordisk Investigational Site (+1 Sites)Clinical Reporting Anchor and Disclosure (1452)Novo Nordisk A/S

Image of Fairbanks Memorial Hospital in Fairbanks, United States.

Phase-Based Progress Estimates

Regional Radiotherapyfor Breast Cancer

This trial is testing whether omitting regional radiation therapy for low-risk breast cancer is non-inferior to usual care.

Fairbanks Memorial Hospital (+99 Sites)Timothy Whelan

Image of University of California, Los Angeles in Los Angeles, United States.

Phase-Based Progress Estimates

DS-1062afor Breast Cancer

This trial is studying a new drug, DS-1062a, for safety and tolerability in people with NSCLC that has not been cured by other treatments. The trial will be in two parts, with the first part looking at dose escalation and the second part looking at additional solid tumors. The trial is expected to last approximately 6 years and will be conducted in the United States and Japan.

University of California, Los Angeles (+11 Sites)Global Team LeaderDaiichi Sankyo, Inc.

Image of University of Alabama at Birmingham Cancer Center in Birmingham, United States.

Phase-Based Progress Estimates

Autologous Hematopoietic Stem Cell Transplantationfor Mantle Cell Lymphoma (MCL)

FDA Approved Drug

This trial is testing if rituximab works better with or without stem cell transplant for mantle cell lymphoma in patients who are in first complete remission.

FDA Approved Drug

University of Alabama at Birmingham Cancer Center (+99 Sites)Timothy Fenske

Image of HonorHealth Research Institute with Barrow Brain and Spine in Phoenix, United States.

Phase-Based Progress Estimates

Hypothermiafor Hypothermia

This trial will study the safety and effectiveness of cooling the body after a spinal cord injury.

HonorHealth Research Institute with Barrow Brain and Spine (+5 Sites)Allan D Levi, MD, PhD

Image of University of Alabama at Birmingham Cancer Center in Birmingham, United States.

Phase-Based Progress Estimates

Ipilimumabfor Serous Cystadenocarcinoma

FDA Approved Drug

This trial is studying nivolumab and ipilimumab in treating patients with rare tumors.

FDA Approved Drug

University of Alabama at Birmingham Cancer Center (+99 Sites)Sandip P Patel

Image of Yale School of Medicine in New Haven, United States.

Phase-Based Progress Estimates

Merotocinfor Inadequate Milk Production

This trial looks at whether a drug can help women with preterm babies and low milk production to make more milk.

Yale School of Medicine (+18 Sites)Global Clinical ComplianceFerring Pharmaceuticals

25 Clinical Trials Baltimore Near Me

Top Cities for Clinical Trials Baltimore

Image of Baltimore in Maryland.

Baltimore

274Active Trials

Johns HopkinsTop Active Site

Image of Los Angeles in California.

Los Angeles

165Active Trials

Children's Hospital Los AngelesTop Active Site